BDX

BECTON DICKINSON & CO

Healthcare • USA

Apr 05 • 04:00PM ET
175.41
+3.14 (+1.82%)
Company Profile

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, ... read more

Full Time Employees 70,000
Phone 201 847 6800
Website https://www.bd.com
CEO Mr. Thomas E. Polen Jr.
IPO Date 1973-02-21
Sector Healthcare
Industry Medical - Instruments & Supplies
Address 1 Becton Drive, Franklin Lakes, NJ 07417-1880
Balance Sheet
Total Cash $747,000,000
Total Debt $19,270,000,000
Current Ratio 1.13
Quick Ratio 0.49
Profitability
Gross Margin 44.50%
Net Margin 7.18%
ROE 5.93%
ROA 2.75%
ROIC 4.45%
Balance Sheet
Total Cash $747,000,000
Total Debt $19,270,000,000
Current Ratio 1.13
Quick Ratio 0.49
Profitability
Gross Margin 44.50%
Net Margin 7.18%
ROE 5.93%
ROA 2.75%
ROIC 4.45%
Name BECTON DICKINSON & CO Sector Healthcare Currency USD Relative Volume 3.14 Market Cap 59534
Current Ratio 1.13 Dividend / Share 3.89 EPS 5.94 Revenue 20640000000 P/S 2.9
P/E 34.5 Beta 0.24 Income 1727000000 Volume 6622735 Average Volume 2108830
Distance to 200DMA -10.74% 200 DMA 232.28 50 DMA 230.38 ROA 3.1 ROE 6.7
Distance to 50DMA -10.0% Return 1Y -13.41% Return YTD -8.19% Forward PE Qtly Growth YOY
Debt/Eq 1.17 P/B 2.4 Dividend Yield 1.7% Net Margin 8.37% Payout Ratio 65.3
Performance
52 Week Range 65.3%
Distance to 200DMA 1.08%
Day Change Percent $1.90
Performance Week $0.95
Performance Month $0.95
Performance Quarter 2024-09-09
Performance YTD $0.95
Performance Year $0.95

Performance Range

Day

$196
Current
Low: High:
Month

$196
Current
Low: High:
Month

$196
Current
Low: High:
Month

$196
Current
Low: High:
Month

$196
Current
Low: High:
Balance Sheet
Total Cash $1,856,000,000
Total Debt $20,110,000,000
Current Ratio 1.17%
Quick Ratio 0.55%
Profitability
Gross Margin 44.50%
Net Margin 7.18%
ROE 5.93%
ROA 2.75%
ROIC 4.45%
Valuation
Price to Earnings 33.62
Price to Book 2.00
Price to Sales 2.41
Price to Free Cash Flow 19.44
Dividends
Payout Ratio 76.29%
Dividend Yield 2.27%
Dividend Amount $1.90
Last Dividend Pay Date 2024-09-09
Last Dividend Paid $0.95
Performance
52 Week Range 65.3%
Distance to 200DMA 1.08%
Day Change Percent $1.90
Performance Week $0.95
Performance Month $0.95
Performance Quarter 2024-09-09
Performance YTD $0.95
Performance Year $0.95
Company Profile

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, ... read more

Full Time Employees 70,000
Phone 201 847 6800
Website https://www.bd.com
CEO Mr. Thomas E. Polen Jr.
IPO Date 1973-02-21
Sector Healthcare
Address 1 Becton Drive, Franklin Lakes, NJ 07417-1880
Histogram - Daily

Balance Sheet
Total Cash $1,856,000,000
Total Debt $20,110,000,000
Current Ratio 1.17%
Quick Ratio 0.55%
Profitability
Gross Margin 0.4520%
Net Margin 0.0840%
ROE 0.07%
ROA 0.03%
Company Profile

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, ... read more

Full Time Employees 70,000
Phone 201 847 6800
Website https://www.bd.com
CEO Mr. Thomas E. Polen Jr.
IPO Date 1973-02-21
Sector Healthcare
Address 1 Becton Drive, Franklin Lakes, NJ 07417-1880
Monthly Win Rate

Balance Sheet (Multi-Column Example)
Dec 2024 Sep 2024 Jun 2024 Mar 2024 Dec 2023 Sep 2023 Jun 2023 Mar 2023
Cash & Short Term Investments 53,775.0 65,171.0 61,801.0 67,150.0 73,100.0 61,555.0 62,482.0 55,872.0
Receivables 59,306.0 66,243.0 43,172.0 41,150.0 50,102.0 60,985.0 39,186.0 35,899.0
Inventory 6,911.0 7,286.0 6,165.0 6,232.0 6,511.0 6,331.0 7,351.0 7,482.0

Latest News

UNH, TGT, BDX: 3 Ridiculously Undervalued Stocks Set to Surge in May 2025
UNH, TGT, BDX: 3 Ridiculously Undervalued Stocks Set to Surge in May 2025

These stocks have declined significantly in the past year and are now below their intrinsic values.

2025-05-14 16:02:33 - 247wallst.com
BD to Announce Financial Results for its Third Quarter of Fiscal 2025
BD to Announce Financial Results for its Third Quarter of Fiscal 2025

FRANKLIN LAKES, N.J. , May 12, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that BD management will host an audio w

2025-05-12 09:00:00 - prnewswire.com
Buy 3 "Safer" Dividend Kings Of 25 From May's 55
Buy 3 "Safer" Dividend Kings Of 25 From May's 55

The May collection of Dividend Kings grew to 55, with Automatic Data Processing and RLI Corporation joining, despite two companies dropping off for not increasing dividends. Six top-yield Dividend Kin

2025-05-06 12:58:48 - seekingalpha.com
Becton Dickinson Vitals Drop: Analysts 'Have Been Wrong' On This Med Tech Stock For Years
Becton Dickinson Vitals Drop: Analysts 'Have Been Wrong' On This Med Tech Stock

Becton Dickinson, and Company BDX lowered its fiscal year 2025 guidance and provided an estimated tariff impact on Thursday.

2025-05-02 16:33:42 - benzinga.com
9 Dividend Aristocrats Potentially Set To Soar, No Matter What Happens Next
9 Dividend Aristocrats Potentially Set To Soar, No Matter What Happens Next

I'm going on a 2-week vacation with my family for my sister's wedding, so I've prepared a comprehensive article with three types of dividend aristocrat recommendations for whateveriscomingnext. Low-vo

2025-05-02 07:00:00 - seekingalpha.com
Medical-products maker Becton Dickinson says cuts in global research funding have hurt sales
Medical-products maker Becton Dickinson says cuts in global research funding hav

Becton Dickinson & Co.'s stock fell more than 15% on Thursday toward its worst one-day loss in 26 years after the medical-products maker said global cuts in research funding are impacting its research

2025-05-01 13:46:00 - marketwatch.com
William Blair downgrades Becton Dickinson on 'disappointing' Q2 update
William Blair downgrades Becton Dickinson on 'disappointing' Q2 update

01 May

2025-05-01 12:15:46 - https://thefly.com
Becton, Dickinson and Company (BDX) Q2 2025 Earnings Call Transcript
Becton, Dickinson and Company (BDX) Q2 2025 Earnings Call Transcript

Becton, Dickinson and Company (NYSE:BDX ) Q2 2025 Results Conference Call May 1, 2025 8:00 AM ET Company Participants Greg Rodetis - Senior Vice President, Treasurer and Head of Investor Relations Tom

2025-05-01 11:44:06 - seekingalpha.com
Becton Dickinson (BDX) Reports Q2 Earnings: What Key Metrics Have to Say
Becton Dickinson (BDX) Reports Q2 Earnings: What Key Metrics Have to Say

Although the revenue and EPS for Becton Dickinson (BDX) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall

2025-05-01 10:36:32 - zacks.com
Cramer's Stop Trading: Becton Dickinson
Cramer's Stop Trading: Becton Dickinson

CNBC's Jim Cramer explains why he is keeping an eye on shares of Becton Dickinson.

2025-05-01 10:22:44 - youtube.com
Becton Dickinson (BDX) Q2 Earnings Top Estimates
Becton Dickinson (BDX) Q2 Earnings Top Estimates

Becton Dickinson (BDX) came out with quarterly earnings of $3.35 per share, beating the Zacks Consensus Estimate of $3.28 per share. This compares to earnings of $3.17 per share a year ago.

2025-05-01 08:45:44 - zacks.com
Medical device maker Becton Dickinson cuts 2025 profit forecast on potential tariff hit
Medical device maker Becton Dickinson cuts 2025 profit forecast on potential tar

Medical device maker Becton Dickinson lowered its annual profit forecast on Thursday, in anticipation of a potential hit from U.S. President Donald Trump's tariffs, sending its shares down 5% in prema

2025-05-01 07:48:47 - reuters.com
BD Reports Second Quarter Fiscal 2025 Financial Results
BD Reports Second Quarter Fiscal 2025 Financial Results

Revenue of $5.3 billion increased 4.5% as reported, 6.0% currency-neutral and 0.9% organic GAAP and adjusted diluted EPS of $1.07 and $3.35, respectively Company updates full-year fiscal 2025 guidance

2025-05-01 06:30:00 - prnewswire.com
BD to Present at Bank of America Securities Health Care Conference
BD to Present at Bank of America Securities Health Care Conference

FRANKLIN LAKES, N.J. , April 30, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the Bank of A

2025-04-30 16:15:00 - prnewswire.com
MedTech Stocks' Earnings to Watch on May 1: BDX, CAH, BAX, DXCM & SYK
MedTech Stocks' Earnings to Watch on May 1: BDX, CAH, BAX, DXCM & SYK

This earnings season so far has reflected a continued recovery in sales for companies within the Medical sector. Earnings have increased year over year, albeit at a slower pace than revenues.

2025-04-30 11:55:39 - zacks.com
BD Board Declares Dividend
BD Board Declares Dividend

FRANKLIN LAKES, N.J. , April 29, 2025 /PRNewswire/ -- The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has decl

2025-04-29 16:20:00 - prnewswire.com